Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
Study NCT ID:
NCT01180816
Status:
COMPLETED
Last Update Posted:
2021-03-04
First Post:
2010-08-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
Sponsor:
Northwell Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-10
First Submit QC Date:
None
Study First Post Date:
2010-08-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-02
Last Update Post Date:
2021-03-04
Last Update Post Date Type:
ACTUAL